Tapewire

NYSE · USD

OWLT

Owlet, Inc.

Export transactions ↓
Tapewire entity
6551
SEC CIK
0001816708
Parsed reports
121

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202602
Feb 202603
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 06, 2026 Filed Oct 9, 2026 01:06 UTC
Workman KurtPresident & CEO
Tax withholdingCommon Stock 20,400 $4.89 $99,756.00
Disclosure

SEC source: 0001868338-26-000004 · wk-form4_1791508013.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,190,679

F1 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of restricted stock units ("RSUs").

Read SEC document
August 12, 2026 Filed Aug 14, 2026 22:09 UTC
Durr LauraDirector
GrantCommon Stock 26,785 $0.00 $0.00
Disclosure

SEC source: 0001816708-26-000094 · wk-form4_1786745392.xml · nonDerivative · entry 1

Durr Laura · CIK 0001319799 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,454

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 20:10 UTC GrantCommon Stock 26,785 $0.00 $0.00
Disclosure

SEC source: 0001984676-26-000005 · wk-form4_1786738213.xml · nonDerivative · entry 1

Gonzales Melissa · CIK 0001984676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,690

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 20:08 UTC
Kim John C.Director
GrantCommon Stock 26,785 $0.00 $0.00
Disclosure

SEC source: 0001868479-26-000005 · wk-form4_1786738088.xml · nonDerivative · entry 1

Kim John C. · CIK 0001868479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,811

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
August 12, 2026 Filed Aug 21, 2026 20:11 UTC
Stoll Marc FDirector
GrantCommon Stock 26,785 $0.00 $0.00
Disclosure

SEC source: 0001416811-26-000004 · wk-form4_1787343101.xml · nonDerivative · entry 2

Stoll Marc F · CIK 0001416811 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,781

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
August 12, 2026 Filed Aug 21, 2026 20:11 UTC
BURKE ZANE MDirector
GrantCommon Stock 26,785 $0.00 $0.00
Disclosure

SEC source: 0001213555-26-000004 · wk-form4_1787343096.xml · nonDerivative · entry 2

BURKE ZANE M · CIK 0001213555 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,787

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
July 08, 2026 Filed Jul 10, 2026 01:30 UTC
Workman KurtPresident & CEO
Tax withholdingCommon Stock 21,001 $5.91 $124,115.91
Disclosure

SEC source: 0001816708-26-000072 · wk-form4_1783647032.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,211,079

Read SEC document
April 28, 2026 Filed Apr 30, 2026 20:33 UTC
Workman KurtPresident & CEO
GrantCommon Stock 850,000 $0.00 $0.00
Disclosure

SEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 6

Workman Kurt · CIK 0001868338 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,232,080

F5 · shares: Represents restricted stock units which will vest as follows: 1/12th of the total original number of restricted stock units shall vest on July 6, 2026 and 1/12th of the total original number of restricted stock units shall vest on the same day of every 3rd month thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 23:18 UTC
Crawford AmandaChief Financial Officer
Tax withholdingCommon Stock 141 $5.66 $798.06
Disclosure

SEC source: 0001816708-26-000025 · wk-form4_1776467916.xml · nonDerivative · entry 1

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,679

F1 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of restricted stock units ("RSUs").

Read SEC document
April 03, 2026 Filed Apr 7, 2026 22:00 UTC
Crawford AmandaChief Financial Officer
Tax withholdingCommon Stock 9,242 $5.10 $47,134.20
Disclosure

SEC source: 0002030797-26-000002 · wk-form4_1775599249.xml · nonDerivative · entry 2

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,820

F4 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of restricted stock units ("RSUs") in connection with the acquisition reported in this Report.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 22:00 UTC
Crawford AmandaChief Financial Officer
GrantCommon Stock 32,032 $4.92 $157,533.38
Disclosure

SEC source: 0002030797-26-000002 · wk-form4_1775599249.xml · nonDerivative · entry 1

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,062

F1 · shares: Reflects shares of Class A common stock ('Shares') issued to the Reporting Person in lieu of her earned 2025 annual incentive bonus, in an amount equal to $157,531, pursuant to a one-time election approved by the Compensation Committee of the Issuer's Board of Directors on March 25, 2026. The acquisition of these Shares was specifically approved in advance by the Compensation Committee in accordance with Rule 16b-3(d) and is therefore an exempt acquisition from the Issuer.

F2 · price: In accordance with the terms of the election, the number of Shares was determined by dividing the cash value of $157,531 by the volume weighted average price (VWAP) of the Shares for the five consecutive trading days ending on the trading day immediately preceding the date of issuance.

F3 · balance_after: Includes shares acquired in the Company's employee stock purchase plan ("ESPP").

Read SEC document
March 25, 2026 Filed Mar 28, 2026 01:50 UTC
Crawford AmandaChief Financial Officer
Tax withholdingCommon Stock 19,191 $5.11 $98,066.01
Disclosure

SEC source: 0002030797-26-000001 · wk-form4_1774662607.xml · nonDerivative · entry 1

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,134

F1 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of previously reported restricted stock units ("RSUs").

Read SEC document
February 27, 2026 Filed Apr 30, 2026 20:30 UTC
Crawford AmandaChief Financial Officer
SaleCommon Stock 6,892 $11.50 $79,258.00
Disclosure

SEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 8

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,800

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
February 26, 2026 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
SaleCommon Stock 12,676 $11.50 $145,774.00
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 8

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,336

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
February 26, 2026 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
GrantCommon Stock 41,666 $0.00 $0.00
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 7

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,012

F1 · date: This transaction is being reported late due to an administrative oversight.

F4 · shares: Represents shares of Common Stock earned with respect to a performance-based RSU granted on November 30, 2025. The Issuer's compensation committee certified the first tranche of attainment of the performance measures on February 26, 2026. These RSUs become vested upon certification of performance measures. This portion is one of six equal tranches, each of which has its own vesting goal based on achievement of cumulative net revenue over the period beginning on January 1, 2025 and ending on December 31, 2028, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
February 25, 2026 Filed Apr 30, 2026 20:30 UTC
Crawford AmandaChief Financial Officer
GrantCommon Stock 20,833 $0.00 $0.00
Disclosure

SEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 7

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,692

F1 · date: This transaction is being reported late due to an administrative oversight.

F4 · shares: Represents shares of Common Stock earned with respect to a performance-based RSU granted on November 30, 2025. The Issuer's compensation committee certified the first tranche of attainment of the performance measures on February 26, 2026. These RSUs become vested upon certification of performance measures. This portion is one of six equal tranches, each of which has its own vesting goal based on achievement of cumulative net revenue over the period beginning on January 1, 2025 and ending on December 31, 2028, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
February 17, 2026 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
SaleCommon Stock 3,540 $10.65 $37,701.00
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 6

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,346

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
January 20, 2026 Filed Jan 23, 2026 02:23 UTC
Crawford AmandaChief Financial Officer
SaleCommon Stock 183 $13.33 $2,439.39
Disclosure

SEC source: 0001628280-26-003171 · wk-form4_1769134982.xml · nonDerivative · entry 1

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,325

F1 · kind: The sales reported on this Form 4 represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units.

Read SEC document
January 20, 2026 Filed Jan 23, 2026 02:22 UTC
Harris JonathanPresident and CEO
SaleCommon Stock 2,311 $13.33 $30,805.63
Disclosure

SEC source: 0001628280-26-003170 · wk-form4_1769134955.xml · nonDerivative · entry 1

Harris Jonathan · CIK 0001698253 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,396

F1 · kind: The sales reported on this Form 4 represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units.

Read SEC document
November 17, 2025 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
SaleCommon Stock 3,423 $10.49 $35,907.27
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 5

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,886

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
October 16, 2025 Filed Apr 30, 2026 22:51 UTC GrantCommon Stock 18,996 $0.00 $0.00
Disclosure

SEC source: 0001984676-26-000002 · wk-form4_1777589466.xml · nonDerivative · entry 1

Gonzales Melissa · CIK 0001984676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,905

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
October 16, 2025 Filed Apr 30, 2026 22:31 UTC
Kim John C.Director
GrantCommon Stock 18,996 $0.00 $0.00
Disclosure

SEC source: 0001868479-26-000002 · wk-form4_1777588293.xml · nonDerivative · entry 1

Kim John C. · CIK 0001868479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,026

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
October 16, 2025 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
SaleCommon Stock 1,851 $8.75 $16,196.25
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 4

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,309

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
October 16, 2025 Filed Apr 30, 2026 20:30 UTC
Crawford AmandaChief Financial Officer
SaleCommon Stock 149 $8.75 $1,303.75
Disclosure

SEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 6

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,859

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
October 16, 2025 Filed May 2, 2026 00:50 UTC
Durr LauraDirector
GrantCommon Stock 18,996 $0.00 $0.00
Disclosure

SEC source: 0001816708-26-000033 · wk-form4_1777683007.xml · nonDerivative · entry 1

Durr Laura · CIK 0001319799 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,669

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
October 16, 2025 Filed Aug 21, 2026 20:11 UTC
Stoll Marc FDirector
GrantCommon Stock 18,996 $0.00 $0.00
Disclosure

SEC source: 0001416811-26-000004 · wk-form4_1787343101.xml · nonDerivative · entry 1

Stoll Marc F · CIK 0001416811 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,996

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
October 16, 2025 Filed Aug 21, 2026 20:11 UTC
BURKE ZANE MDirector
GrantCommon Stock 18,996 $0.00 $0.00
Disclosure

SEC source: 0001213555-26-000004 · wk-form4_1787343096.xml · nonDerivative · entry 1

BURKE ZANE M · CIK 0001213555 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,002

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:14 UTC
Workman KurtDirector
Disposition to issuerWarrant (Right to Buy) · Derivative 131,195 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001628280-25-045154 · wk-form4_1760577238.xml · derivative · entry 2

Workman Kurt · CIK 0001868338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 131,195 shares

Expires 2028-02-17

F1 · kind: On October 10, 2025, the Reporting Person exchanged warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 shares per warrant.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:14 UTC
Workman KurtDirector
GrantCommon Stock 80,235 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-045154 · wk-form4_1760577238.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 419,004

F1 · kind: On October 10, 2025, the Reporting Person exchanged warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 shares per warrant.

F1 · price: On October 10, 2025, the Reporting Person exchanged warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 shares per warrant.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:13 UTC
Kim John C.Director
Disposition to issuerWarrant (Right to Buy) · Derivative 48,621 $0.00 Strike: $4.09 $0.00
Disclosure

SEC source: 0001628280-25-045153 · wk-form4_1760577208.xml · derivative · entry 3

Kim John C. · CIK 0001868479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,621 shares

Expires 2029-03-01

F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:13 UTC
Kim John C.Director
Disposition to issuerWarrant (Right to Buy) · Derivative 131,195 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001628280-25-045153 · wk-form4_1760577208.xml · derivative · entry 2

Kim John C. · CIK 0001868479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 131,195 shares

Expires 2028-02-17

F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:13 UTC
Kim John C.Director
GrantCommon Stock 107,626 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-045153 · wk-form4_1760577208.xml · nonDerivative · entry 1

Kim John C. · CIK 0001868479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,030

F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

F1 · price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:12 UTC ConversionWarrant (Right to Buy) · Derivative 444,601 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-045152 · wk-form4_1760577175.xml · derivative · entry 3

Trilogy Equity Partners, LLC · CIK 0001875623 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 444,601 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:12 UTC ConversionWarrant (Right to Buy) · Derivative 712,915 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-045152 · wk-form4_1760577175.xml · derivative · entry 2

Trilogy Equity Partners, LLC · CIK 0001875623 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 712,915 shares

Expires 2028-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

Read SEC document
October 10, 2025 Filed Oct 16, 2025 01:12 UTC ConversionCommon Stock 686,469 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-045152 · wk-form4_1760577175.xml · nonDerivative · entry 1

Trilogy Equity Partners, LLC · CIK 0001875623 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,567,468

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

F1 · price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 22:56 UTC
Eclipse Continuity GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Early Growth Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Early Growth GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Continuity Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Ventures GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Ventures Fund I, L.P.Director · 10% owner · Director by Deputization
Disposition to issuerSeries B Warrants (Right to Purchase Shares of Common Stock) · Derivative 1,166,935 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-240517 · ownership.xml · derivative · entry 5

Eclipse Continuity GP I, LLC · CIK 0001675124 · Director · 10% owner · Director by Deputization

Eclipse Early Growth Fund I, L.P. · CIK 0001877287 · Director · 10% owner · Director by Deputization

Eclipse Early Growth GP I, LLC · CIK 0001876955 · Director · 10% owner · Director by Deputization

Eclipse Continuity Fund I, L.P. · CIK 0001675126 · Director · 10% owner · Director by Deputization

Eclipse Ventures GP I, LLC · CIK 0001843678 · Director · 10% owner · Director by Deputization

Eclipse Ventures Fund I, L.P. · CIK 0001641394 · Director · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,166,935 shares

Expires not disclosed

F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 22:56 UTC
Eclipse Continuity GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Early Growth Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Early Growth GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Continuity Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Ventures GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Ventures Fund I, L.P.Director · 10% owner · Director by Deputization
Disposition to issuerSeries A Warrants (Right to Purchase Shares of Common Stock) · Derivative 5,300,291 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-240517 · ownership.xml · derivative · entry 4

Eclipse Continuity GP I, LLC · CIK 0001675124 · Director · 10% owner · Director by Deputization

Eclipse Early Growth Fund I, L.P. · CIK 0001877287 · Director · 10% owner · Director by Deputization

Eclipse Early Growth GP I, LLC · CIK 0001876955 · Director · 10% owner · Director by Deputization

Eclipse Continuity Fund I, L.P. · CIK 0001675126 · Director · 10% owner · Director by Deputization

Eclipse Ventures GP I, LLC · CIK 0001843678 · Director · 10% owner · Director by Deputization

Eclipse Ventures Fund I, L.P. · CIK 0001641394 · Director · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 5,300,291 shares

Expires not disclosed

F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 22:56 UTC
Eclipse Continuity GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Early Growth Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Early Growth GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Continuity Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Ventures GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Ventures Fund I, L.P.Director · 10% owner · Director by Deputization
GrantCommon Stock 3,898,906 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-240517 · ownership.xml · nonDerivative · entry 1

Eclipse Continuity GP I, LLC · CIK 0001675124 · Director · 10% owner · Director by Deputization

Eclipse Early Growth Fund I, L.P. · CIK 0001877287 · Director · 10% owner · Director by Deputization

Eclipse Early Growth GP I, LLC · CIK 0001876955 · Director · 10% owner · Director by Deputization

Eclipse Continuity Fund I, L.P. · CIK 0001675126 · Director · 10% owner · Director by Deputization

Eclipse Ventures GP I, LLC · CIK 0001843678 · Director · 10% owner · Director by Deputization

Eclipse Ventures Fund I, L.P. · CIK 0001641394 · Director · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,665,669

F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 22:51 UTC
Susan LiorDirector · 10% owner
Disposition to issuerSeries B Warrants (Right to Purchase Shares of Common Stock) · Derivative 1,166,935 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-240511 · ownership.xml · derivative · entry 5

Susan Lior · CIK 0001832895 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,166,935 shares

Expires not disclosed

F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 22:51 UTC
Susan LiorDirector · 10% owner
Disposition to issuerSeries A Warrants (Right to Purchase Shares of Common Stock) · Derivative 5,300,291 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-240511 · ownership.xml · derivative · entry 4

Susan Lior · CIK 0001832895 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,300,291 shares

Expires not disclosed

F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 22:51 UTC
Susan LiorDirector · 10% owner
GrantCommon Stock 3,898,906 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-240511 · ownership.xml · nonDerivative · entry 1

Susan Lior · CIK 0001832895 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,665,669

F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Read SEC document
October 03, 2025 Filed Apr 30, 2026 20:33 UTC
Workman KurtPresident & CEO
SaleCommon Stock 49,056 $8.46 $415,013.76
Disclosure

SEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 5

Workman Kurt · CIK 0001868338 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,080

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
September 30, 2025 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
GrantCommon Stock 60,024 $0.00 $0.00
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 3

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,160

F1 · date: This transaction is being reported late due to an administrative oversight.

F3 · shares: Reflects RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on December 15, 2026, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
September 30, 2025 Filed Apr 30, 2026 20:33 UTC
Workman KurtPresident & CEO
GrantCommon Stock 14,098 $0.00 $0.00
Disclosure

SEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 4

Workman Kurt · CIK 0001868338 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 431,136

F1 · date: This transaction is being reported late due to an administrative oversight.

F4 · shares: Reflects shares of the Issuer delivered to the reporting person upon satisfaction of performance criteria underlying an award of performance-based RSUs ("PSUs") granted to the reporting person on March 15, 2022.

Read SEC document
September 30, 2025 Filed Apr 30, 2026 20:30 UTC
Crawford AmandaChief Financial Officer
GrantCommon Stock 48,019 $0.00 $0.00
Disclosure

SEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 5

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,008

F1 · date: This transaction is being reported late due to an administrative oversight.

F3 · shares: Reflects RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on December 8, 2026, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
September 17, 2025 Filed Apr 30, 2026 20:33 UTC
Workman KurtPresident & CEO
SaleCommon Stock 1,014 $7.25 $7,351.50
Disclosure

SEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 3

Workman Kurt · CIK 0001868338 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,038

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
September 10, 2025 Filed Apr 30, 2026 20:30 UTC
Crawford AmandaChief Financial Officer
SaleCommon Stock 4,225 $7.06 $29,828.50
Disclosure

SEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 4

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,989

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
August 19, 2025 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
SaleCommon Stock 3,315 $7.72 $25,591.80
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 2

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,136

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
July 17, 2025 Filed Apr 30, 2026 20:46 UTC
Harris JonathanFormer President & CEO
SaleCommon Stock 1,945 $8.03 $15,618.35
Disclosure

SEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 1

Harris Jonathan · CIK 0001698253 · Former President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,451

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document
July 17, 2025 Filed Apr 30, 2026 20:30 UTC
Crawford AmandaChief Financial Officer
SaleCommon Stock 157 $8.03 $1,260.71
Disclosure

SEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 3

Crawford Amanda · CIK 0002030797 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,214

F1 · date: This transaction is being reported late due to an administrative oversight.

F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs").

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.